Kartesia in €32m refinancing for Enterprise-backed Nu-Med

The package will go towards refinancing all existing financial debt and supporting Nu-Med in its growth plan.

This is the first deal for Kartesia in Poland. Capital for the deal will be drawn from Kartesia Credit Opportunities (KCO) IV and V funds. The firm's fourth fund closed on €870m in October 2017 and offers debt and equity packages of €10-60m to European small and mid-cap companies. KCO V was registered in March 2019 and, according to Unquote Data, is still fundraising.

Previous funding
Enterprise acquired a minority stake in the company in 2013, drawing equity from its Polish Enterprise Fund VII. The firm had invested €37.4m in the company as of January 2017.

Enterprise put the asset up for sale, with PwC advising, but did not achieve a sale, according to Unquote sister publication Mergermarket.

Company
Headquartered in Elblag, Poland, Nu-Med is a private operator of four oncology centres in Poland and was founded in 2013. 

People
Kartesia – Giuseppe Mirante (head of DACH credit opportunities).
Nu-Med Group – Paweł Paczkowski (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Refinancing
• CEE
• Healthcare
• Poland
• Refinancing
• Kartesia